Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 2022 Jul 5;119(28):e2209128119. doi: 10.1073/pnas.2209128119

Correction for Ahmed et al., A hypothalamic pathway for Augmentor α-controlled body weight regulation

PMCID: PMC9282272  PMID: 35787061

Medical Sciences Correction for “A hypothalamic pathway for Augmentor α-controlled body weight regulation,” by Mansoor Ahmed, Navjot Kaur, Qianni Cheng, Marya Shanabrough, Evgenii O. Tretiakov, Tibor Harkany, Tamas L. Horvath, and Joseph Schlessinger, which published April 11, 2022; 10.1073/pnas.2200476119 (Proc. Natl. Acad. Sci. U.S.A. 119, e2200476119).

The authors note that “Author Joseph Schlessinger is a member of the Scientific Advisory Board of Celldex Therapeutics, which holds a patent for ‘Regulators of Anaplastic Lymphoma Kinase and Uses Thereof.’” Although this patent and their PNAS article address different questions, the authors are sensitive to any perceptions of competing interest, and thus wish to be transparent about Dr. Schlessinger’s association with Celldex. The competing interest statement has been updated.


Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES